Arbiser, Jack L; Bingaman, Adam; Durham, Megan et al. (2002) SVR angiosarcomas can be rejected by CD4 costimulation dependent and CD8 costimulation independent pathways. Mol Med 8:551-8
|
Bingaman, A W; Ha, J; Durham, M M et al. (2001) Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo. Transplantation 72:1286-92
|
Ha, J; Bingaman, A W; Durham, M M et al. (2001) Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway. Transpl Immunol 9:13-7
|
Baldwin 3rd, W M; Larsen, C P; Fairchild, R L (2001) Innate immune responses to transplants: a significant variable with cadaver donors. Immunity 14:369-76
|
Bingaman, A W; Ha, J; Waitze, S Y et al. (2000) Vigorous allograft rejection in the absence of danger. J Immunol 164:3065-71
|
Bingaman, A W; Pearson, T C; Larsen, C P (2000) The role of CD40L in T cell-dependent nitric oxide production by murine macrophages. Transpl Immunol 8:195-202
|
Bingaman, A W; Waitze, S Y; Alexander, D Z et al. (2000) Transplantation of the bone marrow microenvironment leads to hematopoietic chimerism without cytoreductive conditioning. Transplantation 69:2491-6
|
Durham, M M; Bingaman, A W; Adams, A B et al. (2000) Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol 165:4-Jan
|
Niimi, M; Pearson, T C; Larsen, C P et al. (1998) The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo. J Immunol 161:5331-7
|
Elwood, E T; Larsen, C P; Cho, H R et al. (1998) Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade. Transplantation 65:1422-8
|
Showing the most recent 10 out of 12 publications